ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
yelrom
|
429 |
130K |
49 |
14/03/21 |
14/03/21 |
ASX - By Stock
|
429
|
130K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Can MSB Management tell my why
|
|
yelrom
|
79 |
15K |
1 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
79
|
15K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
17 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
518
|
147K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
13 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
518
|
147K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
0 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
518
|
147K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
1 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
518
|
147K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
0 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
2 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
905
|
286K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Short cover rally starts NOW
|
|
yelrom
|
378 |
93K |
28 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
378
|
93K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
yelrom
|
508 |
172K |
26 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
508
|
172K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Short cover rally starts NOW
|
|
yelrom
|
378 |
93K |
13 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
378
|
93K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
yelrom
|
508 |
172K |
12 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
508
|
172K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
yelrom
|
508 |
172K |
19 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
508
|
172K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
yelrom
|
508 |
172K |
4 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
508
|
172K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
5 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
422
|
145K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
5 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
422
|
145K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
37 |
07/03/21 |
07/03/21 |
ASX - By Stock
|
422
|
145K
|
37
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
10 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
25 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
422
|
145K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
3 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
422
|
145K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
8 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
422
|
145K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
6 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
422
|
145K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
18 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
422
|
145K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
7 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
422
|
145K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
19 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
422
|
145K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
14 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
145K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
16 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
145K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
5 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
145K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
7 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
145K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
24 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
145K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
thread logic
|
|
yelrom
|
5 |
1.5K |
4 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
5
|
1.5K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
2 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
518
|
147K
|
2
|
|
ASX - By Stock
|
MSB |
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
141 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
422
|
145K
|
141
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
yelrom
|
508 |
172K |
5 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
172K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Shorters in drugmaker Mesoblast sweat on crucial capital raising
|
|
yelrom
|
123 |
42K |
7 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
123
|
42K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
7 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
10 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
42 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
11 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
518
|
147K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
yelrom
|
518 |
147K |
4 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
518
|
147K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Investors in drugmaker Mesoblast sweat on crucial capital raising
|
|
yelrom
|
93 |
29K |
14 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
93
|
29K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
yelrom
|
297 |
100K |
19 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
297
|
100K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
What will the discount to 5 day VWAP be for the share placement, and who is the investor?
|
|
yelrom
|
389 |
111K |
17 |
27/02/21 |
27/02/21 |
ASX - By Stock
|
389
|
111K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
8 |
27/02/21 |
27/02/21 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
yelrom
|
272 |
138K |
5 |
27/02/21 |
27/02/21 |
ASX - By Stock
|
272
|
138K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
yelrom
|
272 |
138K |
11 |
27/02/21 |
27/02/21 |
ASX - By Stock
|
272
|
138K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
yelrom
|
297 |
100K |
33 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
297
|
100K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
yelrom
|
272 |
138K |
5 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
138K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Let's just get this done at $10 per MSB share
|
|
yelrom
|
114 |
38K |
27 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
114
|
38K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
16 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
905
|
286K
|
16
|
|